Funding
Imagen Raises Over $100M in Growth Capital for Radiologists and AI

Key PointsImagen raised over $100 million to fund radiologist hiring and AI development together.
View more
- Imagen raised over $100 million to fund radiologist hiring and AI development together.
- New imaging rights cover up to 150 million studies for training and validating future AI models.
- Imagen reported roughly 100% year-over-year radiologist headcount growth making recruitment central to spending.
Imagen Technologies announced on November 18, 2026, that it had raised more than $100 million in growth capital during 2026 and secured rights to up to 150 million additional imaging studies for AI model training. The funding will support radiologist recruitment and retention alongside investments in clinical resources, operational infrastructure, and technology for its physicians.
The capital came from new and existing investors. Imagen reported average year-over-year radiologist headcount growth of approximately 100%, making recruitment a central use of the new funds. The company is pairing that hiring push with AI development intended to improve clinical quality and radiologist efficiency; those improvements are objectives of the investment, not outcomes reported in the announcement.
Imaging Rights Support AI Development
The additional studies span X-ray, CT, MRI, and ultrasound. Imagen plans to use the data access to build and validate models against the diverse, real-world caseloads its radiologists handle. That ties model development directly to its clinical practice, with future systems intended to be trained and assessed against the types of cases its physicians encounter.
Imagen already has an AI development base. Its technology page says its multiple FDA-cleared AI devices were built on a proprietary dataset of more than 200 million imaging studies. The company develops AI in-house and deploys it through its national platform, creating feedback loops across performance, workflow, physician experience, and patient impact. The new rights concern future training and validation; the announcement does not present performance results from models developed with the additional studies.
“The greatest opportunity for AI in radiology isn’t simply to make physicians faster. It’s to give them better tools to deliver exceptional patient care,” said Chief Medical Information Officer Serge Sicular. He said the development goals include improving the quality and consistency of interpretations, streamlining clinical workflows, and giving radiologists more time to focus on cases requiring their expertise.
Recruitment and Clinical Support
The company says it intends to reinvest the benefits of advancing technology into its radiologists and the clinical resources supporting them. Associate Chief Medical Officer Laurence Eckel put the physician-centered model this way: “At Imagen, we’re building the entire practice around the radiologist, from the technology they use to the clinical teams supporting them.”
An August 19, 2026 leadership announcement provides context for that expansion. At the time, Imagen reported services across more than 28 states and more than 2 million imaging studies interpreted annually. It expected its physician team to exceed 200 radiologists by the end of 2026 while expanding partnerships with hospitals, health systems, physician groups, and imaging centers.
Eckel was one of five clinical and operational leaders added in that expansion. His role included helping lead clinical governance, physician development, liaison with the radiologist team, and growth of the national medical practice. The appointments also covered musculoskeletal imaging, interventional radiology, cardiovascular imaging, and operations, adding support around the growing physician group.
The financing and imaging rights give Imagen resources for two connected expansions: a larger radiology practice and a broader base for AI development. Management’s stated model is for technology to support physicians and for the resulting benefits to be reinvested in clinical support. Whether the company can turn those investments into the quality and efficiency gains it is targeting will be central to assessing the growth capital’s impact.












